Neoadjuvant erlotinib benefits selected epidermal growth factor receptor (EGFR)-mutated patients who undergo complete resection of stage IIIA-N2 stage non-small cell
Continue reading »
mypharmacynews.com
Neoadjuvant erlotinib benefits selected epidermal growth factor receptor (EGFR)-mutated patients who undergo complete resection of stage IIIA-N2 stage non-small cell
Continue reading »Researchers have taken advantage of the benefits of DNA immunization over traditional protein-based immunization to elicit monoclonal antibodies (mAbs) against
Continue reading »A team of Tufts University-led researchers has developed three-dimensional (3-D) human tissue culture models for the central nervous system that
Continue reading »A large international research team has discovered a new genetic cause for a severe, difficult-to-treat childhood epilepsy syndrome. Spontaneous mutations
Continue reading »Among more than 72,000 deaths in the U.S. last year, fentanyl—a highly potent prescription opioid often used to lace other
Continue reading »Study from Australia is the first to evaluate a population-level roll-out of pre-exposure prophylaxis (PrEP) in men who have sex
Continue reading »(HealthDay)—A seven-day dose of metronidazole is associated with a reduced likelihood of being Trichomonas vaginalis-positive at test-of-cure compared with single-dose
Continue reading »Researchers from University of California San Diego School of Medicine, with statewide collaborators, report that patients who recorded videos of
Continue reading »A father’s exposure to nicotine may cause cognitive deficits in his children and even grandchildren, according to a study in
Continue reading »Credit: Wellcome Trust Sanger Institute The Deciphering Developmental Disorders (DDD) project aims to provide diagnoses for the families of around
Continue reading »